Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Purecyp
- Development stage
- Unknown
- Lead developer
- Organic Laboratories
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Purecyp is an oral appetite-stimulating syrup developed and marketed by Organic Laboratories. It is a fixed-dose combination of cyproheptadine, a first-generation antihistamine and serotonin antagonist, and tricholine citrate, a lipotropic agent. Purecyp is primarily indicated to stimulate appetite, treat anorexia, and support healthy weight gain in children and adults suffering from undernutrition, malnutrition, or recovering from chronic illnesses. Cyproheptadine works by blocking serotonin receptors in the hypothalamus to stimulate hunger, while tricholine citrate aids in fat metabolism and liver function by promoting bile flow and mobilizing fats. The formulation may also contain sorbitol, which acts as a sweetening syrup base and a mild osmotic laxative to counteract constipation.
- Brand names
- PurecypPurecyp Orange Sf SyrupPurecyp Sugar Free Orange Syrup
- Other names
- cyproheptadine + tricholine citratecyproheptadine hydrochloride + tricholine citrate
02
Targets
HTR2A (Serotonin receptor 5-HT2A)HTR2C (5-hydroxytryptamine 2C receptor)HRH1 (Histamine H1 Receptor)
Beyond the preview
Go deeper on Purecyp.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Purecyp.